Elevated levels of ClpP, HSP60, and HSP10 correlate with higher tumor grade and appear to be driven by HER2/MAPK signaling, specifically through the JNK–CHOP–C/EBPβ axis. This evidence concerns the gene ERBB2 and neoplasm.